Clinical Trial Update: Efficacy and Tolerability CVI (A 12-week, Double-blind, Randomised, Placebo-controlled, Multicentre Trial (CVI) [Phase 3]

View source ↗

Summary

This 12-week Phase 3 double-blind, randomized, placebo-controlled multicenter trial evaluates the efficacy and tolerability of CVI in chronic venous insufficien…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Insufficiency

Drugs mentioned

• CVI

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Venous Insufficiency | Phase 3 | Status: COMPLETED